$0.21 Earnings Per Share Expected for LeMaitre Vascular Inc (NASDAQ:LMAT) This Quarter

Brokerages expect that LeMaitre Vascular Inc (NASDAQ:LMAT) will announce earnings of $0.21 per share for the current quarter, Zacks reports. Three analysts have made estimates for LeMaitre Vascular’s earnings. LeMaitre Vascular reported earnings of $0.43 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 51.2%. The business is expected to report its next quarterly earnings results on Thursday, July 25th.

On average, analysts expect that LeMaitre Vascular will report full year earnings of $0.83 per share for the current year, with EPS estimates ranging from $0.82 to $0.84. For the next year, analysts forecast that the business will post earnings of $0.92 per share, with EPS estimates ranging from $0.89 to $0.95. Zacks’ EPS averages are an average based on a survey of research analysts that cover LeMaitre Vascular.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings data on Wednesday, May 1st. The medical instruments supplier reported $0.17 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.19 by ($0.02). The business had revenue of $28.48 million for the quarter, compared to the consensus estimate of $27.94 million. LeMaitre Vascular had a net margin of 20.92% and a return on equity of 16.76%. LeMaitre Vascular’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.19 EPS.

Several equities research analysts recently issued reports on the company. Barrington Research reissued a “buy” rating and set a $32.00 price objective on shares of LeMaitre Vascular in a research note on Thursday, May 2nd. ValuEngine lowered LeMaitre Vascular from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. BidaskClub lowered LeMaitre Vascular from a “hold” rating to a “sell” rating in a research note on Tuesday, April 16th. Finally, Zacks Investment Research lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Tuesday, May 7th. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $31.00.

A number of hedge funds have recently modified their holdings of LMAT. Bank of Montreal Can lifted its stake in LeMaitre Vascular by 99.1% during the fourth quarter. Bank of Montreal Can now owns 1,113 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 554 shares during the last quarter. BNP Paribas Arbitrage SA lifted its stake in LeMaitre Vascular by 66,640.0% during the first quarter. BNP Paribas Arbitrage SA now owns 3,337 shares of the medical instruments supplier’s stock worth $103,000 after purchasing an additional 3,332 shares during the last quarter. Municipal Employees Retirement System of Michigan bought a new stake in LeMaitre Vascular during the fourth quarter worth about $106,000. Metropolitan Life Insurance Co. NY lifted its stake in LeMaitre Vascular by 373.8% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 5,629 shares of the medical instruments supplier’s stock worth $133,000 after purchasing an additional 4,441 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund bought a new stake in LeMaitre Vascular during the fourth quarter worth about $143,000. 77.10% of the stock is owned by hedge funds and other institutional investors.

NASDAQ:LMAT traded up $0.13 during trading hours on Monday, hitting $27.98. 232,866 shares of the company’s stock traded hands, compared to its average volume of 84,184. The company has a market cap of $547.84 million, a price-to-earnings ratio of 33.31, a P/E/G ratio of 2.80 and a beta of 1.17. LeMaitre Vascular has a 52 week low of $21.79 and a 52 week high of $38.99. The company has a fifty day moving average of $26.91.

The company also recently declared a quarterly dividend, which was paid on Thursday, June 6th. Shareholders of record on Wednesday, May 22nd were paid a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 1.22%. The ex-dividend date was Tuesday, May 21st. LeMaitre Vascular’s dividend payout ratio (DPR) is currently 40.48%.

About LeMaitre Vascular

LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature.

Read More: What does an outperform rating mean?

Get a free copy of the Zacks research report on LeMaitre Vascular (LMAT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.